Ahmed Abou-Zamzam, MD Head, Cardiovascular & Thoracic Surg, Vascular Division School of Medicine Associate Professor, Cardiovascular & Thoracic Surg School of Medicine

Research & Grantsmanship 

  Funded Research Project (PI)

• Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA), a multicenter, randomized, placebo-controlled clinical trial ( 11/2004 - 1/2006 )

• Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA), a multicenter, randomized, placebo-controlled clinical trial ( 11/2004 - 6/2005 )

• "A double-blind, randomized, placebo-controlled study to assess the efficacy and safety of Circulase for the treatment of critical leg ischemia," a multicenter, Phase III clinical trial. ( 6/2001 - 6/2002 )

• "A double-blind, randomized, placebo-controlled study to investigate the efficacy and safety of Circulase in conjunction with peripheral revascularization for the treatment of critical leg ischemia." ( 6/2001 - 6/2002 )

• Research database for patients enrolled in the vascular surgery clinic ( 12/2005 - Present )

  Abstracts Reporting Research -- Non-Peer Reviewed

• Outcomes of patients presenting with critical limb ischemia, a prospective study. ( 8/2001 - 10/2006 )